[144] UGI CORP /PA/ SEC Filing

Rhea-AI Filing Summary

UGI Corporation disclosed a planned sale of restricted stock under Rule 144. The notice covers the potential sale of 15,000 shares of common stock through Morgan Stanley Smith Barney LLC on or around 11/25/2025 on the NYSE. The filing lists an aggregate market value of $580,135.50 for these shares and notes that UGI had 214,527,913 shares outstanding at the time referenced. The seller acquired the 15,000 shares on 11/25/2025 by exercising options under a registered plan and paid the exercise price in cash. The person for whose account the securities are to be sold represents that they are not aware of undisclosed material adverse information about UGI’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	15000	580135.50	214527913	11/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/25/2025	Exercise of options under a registered plan	Issuer			15000	11/25/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does UGI (UGI) disclose in this Form 144 filing?

The filing discloses a planned Rule 144 sale of 15,000 shares of UGI common stock by an affiliated holder, including details on acquisition, broker, and trading venue.

How many UGI shares are planned to be sold and on what exchange?

The notice covers a potential sale of 15,000 shares of UGI common stock on the NYSE, to be executed through Morgan Stanley Smith Barney LLC.

What is the aggregate market value of the UGI shares covered by this notice?

The aggregate market value of the 15,000 UGI shares covered by the notice is listed as $580,135.50.

How and when were the UGI shares being sold acquired?

The 15,000 UGI common shares were acquired on 11/25/2025 through the exercise of options under a registered plan, with the exercise price paid in cash.

How many UGI shares were outstanding according to the Form 144 notice?

The Form 144 indicates that 214,527,913 shares of UGI common stock were outstanding as of the referenced date, providing a baseline for the issuer’s equity size.

What representation does the seller make about information on UGI in this notice?

The person for whose account the securities are to be sold represents that they do not know of any material adverse information about UGI’s current or prospective operations that has not been publicly disclosed.